All the Way from Teeth to Tee: Hole in One
6th Edition of All India Dental Fraternity Invitation Golf Tournament in Class & Style Manesar/ New Delhi: Dentistry is now a high- end domain with class and style. 6th Edition…
Zydus Lifesciences Q4FY26 net profit rises 9%
Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…
Chemists strike on May 20: Reasons behind today’s all-India strike
While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…
AbbVie loses patent plea for Hep C drug
New Delhi: The Indian Patent Office has refused to grant a secondary patent to AbbVie for its blockbuster Hepatitis C drug combination glecaprevir/pibrentasvir, sold globally under the brand name Maviret.…
GSK’s Calpol a well-known trademark: High Court
New Delhi: In a relief to UK-headquartered GlaxoSmithKline Pharmaceuticals (GSK), the Delhi High Court has declared its pain and fever medicine ‘Calpol’ as a well-known trademark that has acquired extensive…
3 arrested for allegedly posing as doctors using forged MBBS degrees
Bhopal- A shocking case of medical fraud has come to light in Madhya Pradesh’s Damoh, where police have apprehended three men for allegedly posing as doctors at “Sanjeevani Clinics” operating…
Commissioner FDA reviews enforcement measures
Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…
Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements
Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…
Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer
Mumbai: Cancer patients and their caretakers in India often spend long, arduous hours in hospitals for conventional treatment. But now with the launch of the world’s first subcutaneous or under-the-skin…

WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelled
DDA seizes suspected counterfeit asthma medicine in nationwide crackdown
HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses
Eli Lilly launches cancer drug Tanstrive in India
Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals
Centre eases BIS quality compliance with new risk-based framework for manufacturers
SS Innovations International aces Race beating Global Giants in Surgical Robotics
‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility
India curbs supply of IVF consumables to unregistered clinics
Maha FDA seizes counterfeit skincare products; FIR registered








